NSEUpdates11 Aug 2026 · 11 Aug 2026, 07:07 pm
Updates
Zydus Lifesciences Limited · ZYDUSLIFE
✦ AI SummaryRegulatory
Zydus Lifesciences Limited has reported a violation of the SEBI (Prohibition of Insider Trading) Regulations, 2015, by one of its Designated Persons, Mr. Ashutosh Patil, who traded in the company's equity shares without adhering to the Code of Conduct.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Zydus Lifesciences Limited has informed the Exchange regarding 'Reporting of violation of Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015'.
Attachments (1)
📄pdf
Download →
Cadilahc_11082026190609_SEIntimation11082026.pdf
View document text
August 11, 2026
Listing Department Code: 532321
BSE LIMITED
P. J. Towers, Dalal Street,
Mumbai–400 001
Listing Department Code: Zyduslife
NATIONAL STOCK EXCHANGE OF INDIA LIMITED
Exchange Plaza, C/1, Block G,
Bandra Kurla Complex,
Bandra (E),
Mumbai–400 051
Sub: Reporting of violation of Code of Conduct under SEBI (Prohibition of Insider Trading)
Regulations, 2015 (“SEBI PIT Regulations”)
Ref: SEBI circular No. SEBI/HO/ISD/ISD/CIR/P/2020/135 dated July 23, 2020
Dear Sir,
In terms of SEBI circular no. SEBI/HO/ISD/ISD/CIR/P/2020/135 dated July 23, 2020 ("SEBI
Circular") with respect to reporting to the Stock Exchanges regarding violations under SEBI
PIT Regulations relating to the Code of Conduct (“CoC”), please find attached herewith report
of the Company for violation of CoC by a Designated Person. Details of the violation are
provided in Annexure-“A” attached herewith.
Kindly take note of the same.
Thanking you,
Yours faithfully,
For, ZYDUS LIFESCIENCES LIMITED
DHAVAL N. SONI
COMPANY SECRETARY & COMPLIANCE OFFICER
MEMBERSHIP NO. FCS7063
Annexure-“A”
Report by Zydus Lifesciences Limited for violations
related to Code of Conduct under SEBI (Prohibition of Insider Trading)
Regulations, 2015
Sr. No. Particulars Details
1. Name of the listed company/ Zydus Lifesciences Limited
Intermediary/Fiduciary
2. Please tick appropriate checkbox Listed Company
Reporting in capacity of :
☐ Listed Company
☐ Intermediary
☐ Fiduciary
3. A. Details of Designated Person (DP)
i. Name of the DP Mr. Ashutosh Patil
ii. PAN of the DP EEKPP9093G
iii. Designation of DP Associate Research Scientist
iv. Functional Role of DP Project Manager
v. Whether DP is Promoter or belongs to No
Promoter Group
B. If Reporting is for immediate relative of DP
i. Name of the immediate relative of DP Not Applicable
ii. PAN of the immediate relative of DP Not Applicable
C. Details of transaction(s)
i. Name of the scrip NSE Symbol: Zyduslife
BSE Symbol: 532321
ii. No of shares traded and value (Rs.) (Date- Purchase and sell of 171 equity
wise) shares on March 11, 2026, and
May 22, 2026, respectively. The
value of shares traded is Rs.
3,36,166/- only.
D. In case value of trade(s) is more than Rs. 10 lacs in a calendar quarter
i. Date of intimation of trade(s) by concerned DP Not applicable
/ director / promoter / promoter group to
Company under regulation 7 of SEBI (PIT)
Regulations, 2015
ii. Date of intimation of trade(s) by Company to Not applicable
stock exchanges under regulation 7 of SEBI (PIT)
Regulations, 2015
4. Details of violations observed under Code of Mr. Ashutosh Patil-Designated
Conduct Person has inadvertently traded
(contra trade) in equity shares of
the Company and hence it is
considered as violation of
regulation 9 read with clause 10 of
Schedule B of SEBI PIT Regulations
and the CoC adopted by the
Company.
5. Action taken by Listed company/ Intermediary/ The Company has issued a warning
Fiduciary letter to Mr. Ashutosh Patil-
Designated Person to strictly
adhere to the provisions of the
SEBI PIT Regulations and CoC and
also to remain diligent and be in
complete compliance with the CoC
henceforth to avoid any actions
for any subsequent violations.
Accordingly, Mr. Ashutosh Patil
has provided apology letter for
trading (contra trade) in equity
shares of the Company.
6. Reasons recorded in writing for taking action He has admitted that the trade
stated above executed was purely unintentional
and due to oversight.
7. Details of the previous instances of violations, if No previous instances of violation
any, since last financial year are observed.
8. If any amount collected for Code of Conduct violation(s): An amount of Rs. 18,797/-
being the profit gained by Mr. Ashutosh Patil, by entering into contra trade, is
transferred online by him directly to IEPF.
i. Mode of transfer to SEBI - IPEF Online
(Online/Demand Draft)
ii. Details of transfer/payment
In case of Online:
Particulars Details
Name of the Ashutosh Patil
transferor
Bank Name, ICICI Bank,
branch and Residency Road,
Account number Branch, Bangaluru
Account No.
742901500565
UTR/Transaction 260810281845192
reference
Number
Transaction date August 10, 2026
Transaction Rs. 18797/-
Amount (in Rs.)
In case of Demand Draft (DD): Not applicable
Particulars Details
Bank Name and
branch
DD Number
DD date
Transaction date
DD amount (in Rs.)
9. Any other relevant information The Audit Committee at its
meeting held on August 11, 2026,
took note of the same.
Yours faithfully,
For, ZYDUS LIFESCIENCES LIMITED
DHAVAL N. SONI
COMPANY SECRETARY & COMPLIANCE OFFICER
PAN: BEWPS0561P
Email id: dhavalsoni@zyduslife.com
Date: August 11, 2026
Place: Ahmedabad